Treatment of coagulation disoreders in patients with diabetes mellitus type II

Pokrovsky A.V.; Doguzhieva R.M.; Titova M.I.; Demidova V.S.; Lebedeva A.N.

doi:https://doi.org/

Pokrovsky A.V.

Otdelenie khirurgii sosudov Instituta khirurgii im. A.V. Vishnevskogo, Moskva

Doguzhieva R.M.

Otdelenie khirurgii sosudov Instituta khirurgii im. A.V. Vishnevskogo, Moskva

Titova M.I.

Otdelenie khirurgii sosudov Instituta khirurgii im. A.V. Vishnevskogo, Moskva

Demidova V.S.

Otdelenie khirurgii sosudov Instituta khirurgii im. A.V. Vishnevskogo, Moskva

ORCID: 0000-0003-3187-4408

Lebedeva A.N.

Otdelenie khirurgii sosudov Instituta khirurgii im. A.V. Vishnevskogo, Moskva

Treatment of coagulation disoreders in patients with diabetes mellitus type II

Authors:

Pokrovsky A.V., Doguzhieva R.M., Titova M.I., Demidova V.S., Lebedeva A.N.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2010;(11): 29‑33

Read: 771 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Pokrovsky AV, Doguzhieva RM, Titova MI, Demidova VS, Lebedeva AN. Treatment of coagulation disoreders in patients with diabetes mellitus type II. Pirogov Russian Journal of Surgery. 2010;(11):29‑33. (In Russ.)

Подписка 2026 Хирургия. Журнал им. Н.И. Пирогова (Pirogov Russian Journal of Surgery)

Использование инфографики авторами научных работ

Close metadata

Abstract:

Efficacy of out-hospital treatment of coagulation disorders in patients with diabetes mellitus type II (DMII) in comparison with non-diabetic patients after aortic-femoral reconstruction was studied. Long-term results were obtained within 65,1±3,95 months after surgery. Data of 67 patients were obtained, of them 32 had severe DMII, 35 patients had no diabetic disorders. 94% of patients had various hypercoagulation disorders and thrombophilia stage I-II. Desagregant therapy was noneffective in 70,1% of patients. Patients with atherosclerosis after reconstructive vascular surgery showed disorders of both thrombocytic and plasma links of coagulation, which requires combined (anticoagulant and desagregant) therapy. Patients with DMII require also blood glucose and HbA1c control postoperatively.

Keywords:

diabetes mellitus type II

thrombogenesis

coagulation

Authors:

Pokrovsky A.V.

Otdelenie khirurgii sosudov Instituta khirurgii im. A.V. Vishnevskogo, Moskva

Doguzhieva R.M.

Otdelenie khirurgii sosudov Instituta khirurgii im. A.V. Vishnevskogo, Moskva

Titova M.I.

Otdelenie khirurgii sosudov Instituta khirurgii im. A.V. Vishnevskogo, Moskva

Demidova V.S.

Otdelenie khirurgii sosudov Instituta khirurgii im. A.V. Vishnevskogo, Moskva

ORCID: 0000-0003-3187-4408

Lebedeva A.N.

Otdelenie khirurgii sosudov Instituta khirurgii im. A.V. Vishnevskogo, Moskva

Close metadata

References:

Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nym sakharnym diabetom. Pod red. I.I. Dedova, M.V. Shestakovoi. M 2007.
Barkagan Z.S. Plyusy i minusy profilakticheskogo i lechebnogo primeneniya aspirina pri koronarnoi bolezni serdtsa. V kn: "Progress i problemy v lechenii zabolevanii serdtsa i sosudov". Materialy yubileinoi konferentsii Sankt-Peterburgskogo universiteta. St-Peterburg 1997; 7-8.
Barkagan Z.S., Kotovshchikova E.F. Prichiny uspekha i neudach primeneniya aspirina pri ishemicheskoi bolezni serdtsa. V kn: "Progress i problemy v lechenii zabolevanii serdtsa i sosudov". Materialy yubileinoi konf. Sankt-Peterburgskogo universiteta. St-Peterburg 1997; 8.
Mareev V.Yu. Vzaimodeistvie lekarstvennykh sredstv pri lechenii bol'nykh s serdechno-sosudistymi zabolevaniyami. Ingibitory APF i aspirin. Est' li povod dlya trevogi? Serdtse 2002; 1: 4: 161-168.
Pokrovskii A.V., Zotikov A.E. Klinicheskaya angiologiya. Pod red. akad. RAMN A.V. Pokrovskogo. M: Meditsina 2004; 2: 153.
Pokrovskii A.V., Zotikov A.E., Yudin V.I. Nespetsificheskii aortoarteriit. M 2002; 256.
Prikaz Departamenta zdravookhraneniya pravitel'stva Moskvy ot 31.07.95 №448 "O moskovskikh gorodskikh standartakh ambulatorno-poliklinicheskoi meditsinskoi pomoshchi dlya vzroslogo naseleniya" (po sostoyaniyu na 23 yanvarya 2008 g.). Glava III. Bolezni endokrinnoi sistemy. M 1995; 3-4.
Titova M.I., Kalashnikova S.V. Izmeneniya svertyvayushchei sistemy i gemostaziologicheskie oslozhneniya pri endovaskulyarnykh operatsiyakh, mekhanizmy tromboobrazovaniya. Sosudistoe i vnutriorgannoe stentirovanie. Pod red. L.S. Kokova, S.A. Kapranova, B.I. Dolgushina i dr. M 2003; 232-250.
Titova M.I., Kurochkina A.I., Rudneva V.G. Posleoperatsionnye narusheniya sistemy gemostaza. V sbornike: "Aktual'nye voprosy khirurgii". Pod red. V.D. Fedorova. M 1995; 302-309.
Fedorov V.D., Titova M.I., Ganzha P.F. Ostryi venoznyi tromboz, novye napravleniya v profilaktike i lechenii. Khirurgiya 1998; 12: 60-62.
Bhatt D.L., Chew D.P., Hirsch A.T. et al. Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation 2001; 103: 363-368.
Carcia Trade L.J., Creight L.J., Gaffney L.J. Diabetes mellitus as an hypercoagulable state; its relationship with fibrin fragments and vascular damage. Thromb Res 1987; 533-540.
Chen W.-H., Lee P.Y., Ng W. et al. Prevalence, profile, and predictors of aspirin resistance measured by the Ultegra rapid platelet function assay-ASA in patients with coronary artery disease. J Am Coll Cardiol 2005; 45: 382.
Gusu P.A., Kottke-Marchant K., Poggio E.D. et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 2001; 88: 230-235.
Gum P.A., Kottke-Marchant K., Welsh P.A. et al. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003; 41: 961-965.
Kvasnika J. et al. Cas Lec Cesk 1996; 135: 6: 174-177. Cardiosite.ru.
Kjalke M. et al. Jn: Abstract Collection, Recombinant Factor Vila 1997; 25-26. Cardiosite.ru.
Muhlfelder T.W. et al. Thromb Haemost 1999; 81: 146-150. Cardiosite.ru.
Michelson A.D., Cattaneo M., Eikelboom J.W. et al. Aspirin Resistance: Position Paper of the Working Group on Aspirin Resistance, Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2005; 3: 1-3.
Petersen L.C. et al. Thromb Res 1995; 79: 1-47. Cardiosite.ru.
Pui-Yin Lee et al. Am J Med 2005; 118: 723-727. Cardiosite.ru.
Wang T.H., Bhatt D.L., Topol E.J. Aspirin and clopidogrel resistance: an emerging clinical entity. Eur Heart J 2006; 27: 647-654.
Zimmerman N. et al. Circulation 2003; 108: 542-547. Cardiosite.ru.